Adenosine
These highlights do not include all the information needed to use Adenosine Injection, USP safely and effectively. See full prescribing information for Adenosine Injection, USP.Adenosine Injection, USP For intravenous useInitial U.S. Approval: 1995
Approved
Approval ID
f2f1b4c5-1cfe-4b67-95b4-e1a0efc87777
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 29, 2024
Manufacturers
FDA
Akorn
DUNS: 117693100
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Adenosine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code17478-544
Application NumberANDA090450
Product Classification
M
Marketing Category
C73584
G
Generic Name
Adenosine
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 29, 2024
FDA Product Classification
INGREDIENTS (3)
AdenosineActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT